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Abstract: Blastocystis hominis can be found in the fecal sample of both healthy individuals without symptoms and 
those having gastrointestinal problems. Therefore, the pathogenicity and pathophysiology remain controversial. 
The aim of this study was to determine if Blastocystis hominis is a causative agent of diarrhea and investigates its 
prevalence among patients visiting King Abdulaziz University Hospital, Jeddah, Saudi Arabia from January 2013 
till June 2015 and to determine any significant correlation between age, gender, nationality and other parasitic 
infection in the presence of Blastocystis hominis. Data were collected from Parasitology lab, using the database at 
King Abdulaziz University Hospital, Jeddah, Saudi Arabia and statistical analysis were done by utilizing Statistical 
package for social science program (SPSS). Out of 3,035 of total stool analysis requested, 157 samples were 
positive for B. hominis (5.2%). 80 (51.6%) were males, and 76 (48.4%) were females. The distribution of B. 
hominis infection was elevated in 31-50 aged groups (25.5%). There was a statistically significant correlation 
between the presence of Blastocystis and diarrhea at p < 0.05 and there was no correlation between age, sex, 
nationality and other parasites with positivity of B. hominis. Blastocystis can be considered as a causative agent of 
diarrhea. Further studies need to be done in order to investigate its role in pathogenicity and more data must be 
revised to assess the pathogenicity of Blastocystis subtypes. 
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1. Introduction 
 
Intestinal parasitic infections are considered a 
primary public health problem worldwide, especially in 
developing countries1-5. These protozoan infections 
have relatively a frequent symptom such as diarrhea and 
gastrointestinal problems, but asymptomatic patient 
may also be found. Blastocystis hominis is a common 
intestinal parasite that infects humans6. Prevalence of 
Blastocystis hominis is variable. Prevalence range 
between (0.5-60%) have been reported1-24. Regardless 
to other protozoan parasite, diarrhea due to Blastocystis 
hominis in healthy immunocompetent people is usually 
mild and self-limiting. Nevertheless, in 
immunosuppressed patients severe and prolonged 
diarrhea has been reported6. Although a few case 
reports show that B. hominis may be pathogenic and can 
be an opportunistic pathogen in immunocompromised 
patients. Other studies suggested no pathogenic role of 
Blastocystis3,11. An assortment of signs and symptoms 
of Blastocystis ranged from intestinal symptoms to 
cutaneous disorders. Blastocystis were the most 
frequent parasite present in patients with HIV infection 
and AIDS who had chronic diarrhea. Moreover, it was 
most frequently isolated from patients with cancer. In 
underdeveloped countries, children with Blastocystis 
have a higher incidence of infection. Blastocystis 
although probably may seem to be a zoonotic infection 
due to those who are in a relative contact with animals 
which gives increased risk of acquisition of 
Blastocystis, it was also reported in expatriates with 
traveler’s diarrhea9,24. 
Blastocystis have been reported in (5.67%) of 
patient with GI symptoms compared to (3.43%) in 
patients without GI symptoms with a correlation 
between the presence of this parasite and GI 
symptoms3,9,13,19,26. Abdominal pain and diarrhea are the 
most frequent symptoms accompanying Blastocystis 
infection9,13,17,25. A higher concentration of parasite is 
more likely to be correlated with symptoms than a 
lower number of parasite as some studies have 
suggested while disputed by others18,26. Dialysis 
patients and those with IBS and/or ulcerative colitis 
should always be considered for Blastocystis when GI 
symptoms are refractory and cannot be released2,9,11,17,24-
27
. 
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There are at least 13 subtypes of Blastocystis. Some 
are recovered from human stool while others were 
recovered from animals8,11,13,16,26,28-31. Pathogenicity 
comparison between subtypes is still controversial. This 
study was aimed to determine if Blastocystis hominis is 
a causative agent of diarrhea and investigate its 
prevalence among patients visiting King Abdulaziz 
University Hospital, Jeddah, Saudi Arabia from January 
2013 till June 2015 and to detriment any significant 
correlation between age, gender, nationality and other 
parasitic infection with the presence of Blastocystis 
hominis. 
 
2. Material and method 
 
2.1 Sample collection 
This was a retrospective study that included data 
collected and annualized between January 2013 till June 
2015 from Parasitology Laboratory at King Abdulaziz 
University Hospital, Jeddah, Saudi Arabia. Overall, 
3,035 total stool analysis were requested between 
January 2013 till June 2015. Of these, 157 samples 
were positive for B. hominis. Other data variables taken 
into consideration were age, sex, nationality, occult 
blood and the presence of other parasite. 
 
2.2  Stool analysis 
Stool samples were collected in a clean and dry 
screw top container after giving the instructions of 
collections to the patient. Samples were analysed using 
Biosepar® ParasiTrap diagnostic system for detection of 
parasites in feaces according to the manufacturer 
instructions32. 
 
2.3  Occult blood 
For hidden blood in gastrointestinal bleeding of GI 
disorders, HEMOSURE® test were used for qualitative 
determination of fecal occult blood according to the 
manufacturer instructions33. 
 
2.4  Data processing and statistical analysis 
Statistical package for social science software 
(version 16) and Microsoft Excel were used for data 
processing and statistical analysis. 
 
3. Result 
 
One hundred and fifty-seven (5.2%) samples were 
positive of B. hominis as described above. Positive 
samples were seen in different age groups as shown in 
Table 1. Among 157 positive B. hominis samples, 
51.6% of samples were from male patients. Positive 
samples were from different nationalities as shown in 
Table 2. Other parasites detected in positive samples 
and their frequencies are shown in Table 3. Occult 
blood was positive in few samples. There was a 
statistically significant correlation between the presence 
of Blastocystis and diarrhea at p < 0.05. However, there 
was no correlation between age, sex, nationality and 
other parasites with positivity of B. hominis. 
 
Table 1. Age groups of patients positive for Blastocystis hominis. 
 
Age group Frequency Percentage 
0-5 2 1.3% 
6-15 24 15.3% 
16-30 38 24.2% 
31-50 40 25.5% 
51-70 29 18.5% 
 
Table 2. Nationalities of patients with Blastocystis hominis positive 
samples. 
 
Nationality Frequency 
Saudi 53 
Yamani 30 
Indian 16 
Palestinian 9 
Pakistani 8 
Egyptian 7 
Philippine 7 
Sudanese 6 
Ethiopian 4 
Syrian 4 
Somalian 4 
Others 9 
 
Table 3. Other parasites detected in Blastocystis hominis positive 
samples. 
 
Other parasites Frequency 
Entamoeba coli cyst 5 
Entamoeba histolytica cyst 3 
Endolimax nana cyst 2 
Giardia lamblia cyst 1 
Trichuris trichiura ova 1 
 
4. Discussion 
 
Intestinal parasitic infections are considered as 
primary public health problem worldwide5. Diarrhea is 
the most frequent symptom for intestinal parasitic 
infections, but asymptomatic individual can also be 
found. Blastocystis hominis is a common intestinal 
parasite that is found in human fecal samples and has 
been identified recently in patients with diarrhea, 
although its role remains controversial due to its 
presence also in healthy individual2. 
Among different geographic regions, the diversity 
of the prevalence rate of Blastocystis hominis has been 
reported. The reported prevalence ranged (2-50%)3,9. 
While other studies revealed a range between (0.5-
60%)4,11-13,16,23. The present study shows a prevalence of 
(5.2%) which is within the range of previous studies.  
Different factors may contribute to the prevalence of 
intestinal parasitic infections such as sanitation and 
hygiene. Although, developed countries have a lower 
prevalence compared to developing countries taking the 
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variation in different regions of the same country into 
consideration9. Differences in the diagnostic methods 
used properly, may lead to a significant difference that 
can be related to the epidemiological setting in reported 
prevalence. In this regard, the true prevalence of the 
infection is not known. Therefore, result does not 
necessarily reflect the population’s real prevalence, 
which is considered one of the limitations of the study.  
Blastocystis hominis is considered as the most 
frequently identified parasite in human stool 
specimens18. There was no statistically significant 
correlation between nationality and B. hominis 
infection. This may be due to the subjectivity of data 
collection of this study. Therefore, further studies need 
to be conducted on a wide range to compare the 
frequency of B. hominis infection with other countries.  
Moreover, there was no statistically significant 
correlation between age and B.  hominis infection. This 
is an agreement with other studies6,16,35. However, 
epidemiological and diagnostic features of Blastocystis 
infection in symptomatic patients in some studies 
showed a statistically significant higher frequency of 
Blastocystis infection among 20-29 years group 
compared to other age groups (χ2: 13.68, p = 0.03)13 
while in this study Blastocystis hominis was 
predominantly between 31-50 age group. This 
difference could be due to different lifestyle and 
hygiene, as well as the specificity of samples that was 
collected from a hospital, included pediatric and young 
patients with gastrointestinal symptoms and (15.24%) 
of these samples n=94 were positive for Blastocystis13. 
Another study observed the distribution of B. hominis 
infection was high (34.9%) in 7-13 aged children (χ2 = 
306.8; p = 0.001)1. In contracts to another study which 
was highly significant among 0-19 age group among 
other age groups (p = 0.039)36. On the other hand, 
different study had observed that age was significantly 
correlated with discrete subtypes with those who had 
ST1 being younger (27 years) compared to ST3, ST4 
and ST7 median ages (60, 54 and 46 years, 
respectively)36.  
According to gender, results indicate that there was 
no statistically significant correlation with B. hominis 
infection and this was in agreement with 
others3,6,9,11,15,19,36. Moreover, our results were in 
disagreement with a study that observed the relation 
between Blastocystis which occurs 2.34 times more 
frequently in subjects with IBS than in non IBS subjects 
(p > 0.01). The difference only in males was significant 
by comparing the prevalence of Blastocystis within 
male and female subgroups either with or without IBS 
(36.8% for IBS males’ vs 4.8% for control males) 
which was confirmed by the multivariate analysis26. 
With respect to the association of Blastocystis with 
other parasites, two cases were described with acute 
dysenteric diarrhea concomitantly with E. histolytica in 
one patient and G. duodenalis in the other2. On the 
other hand, and among Iranian population study, B. 
hominis was mostly found with E. coli in control group 
and G. lamblia in case group while in other 21 patients 
B. hominis was detected alone without other parasites 
(55%). However, they found that there was no 
significant difference in the distribution of B. hominis 
cohabitation with other intestinal parasites in case 
compared to control group3. Even though there were 
few other parasites presented with B. hominis, our result 
showed that there was no significant correlation.  
This study showed a statistically significant 
correlation between the presence of Blastocystis and 
diarrhea (p < 0.05). This is in agreement with other 
studies examining the correlation between the presence 
of B. hominis, diarrhea, and abdominal pain9,13,16,24,26.  
In conclusion, the role of Blastocystis hominis has 
not been obviously defined. However, Blastocystis 
should be taken into consideration, as a causative agent 
of human disease, particularly when the parasite is 
present in enormous numbers in fecal specimens while 
absence of other recognized pathogens. The question of 
whether there are other factors involve the parasite in its 
capability to be opportunistic in immunocompromised 
and immunocompetent individuals has not yet been 
clearly countered. Blastocystis associated symptoms 
and its ability to produce clinically significant disease 
remain unexplained. Genetic variability has been 
notified to play role in the pathogenicity of Blastocystis 
so molecular field should be taken into consideration to 
determine the source and route of infection. 
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